Physician profile
Sandhya K Balaram
NPI 1215926837
$2,889.81
in general payments reported to CMS, 2019-2025
9 companies · $544 in 2025
The $544 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,723 · 2020: $75.45 · 2021: $23.63 · 2022: $67.34 · 2023: $202 · 2024: $255 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,947.36 | 2019-2024 | Mitraclip, Epic |
| Kestra Medical Technology Services, INC. | $375.03 | 2025 | Assure Wcd |
| Atricure, INC. | $176.94 | 2019-2023 | |
| Edwards Lifesciences Corporation | $133.87 | 2025 | |
| Baxter Healthcare | $89.57 | 2023-2024 | Preveleak, Floseal |
| Cook Medical LLC | $81.59 | 2020-2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $34.72 | 2025 | |
| Ethicon US, LLC | $26.12 | 2024 | Harmonic |
| Abiomed | $24.61 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandhya Balaram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.